Reactive oxygen species (ROS), such as hydrogen peroxide (H 2 O 2 ), superoxide anion radicals (O 2 Ϫ⅐ ), and hydroxyl radicals (OH⅐), are generated in cells by various pathways. Several cellular enzymatic complexes have been identified as sites of ROS production, such as NADPH cytochrome P450 reductases, hypoxanthine/ xanthine oxidase, NADPH oxidase, lipoxygenase, peroxidases, and cyclooxygenases (1) . However, mitochondria are believed to be the major source of ROS in aerobic cells (2, 3) , as during oxidative phosphorylation ϳ1-2% of all transported electrons escape and reduce O 2 to O 2 Ϫ⅐ (4, 5) . Recently, ROS have been identified as key redox regulators of cellular signaling cascades, metabolic processes, and transcription factors.
Redox regulation has been shown to play a crucial role in cell survival by the activation of kinases, oncogenic Ras signaling, lipid metabolism, calcium signaling, and activation of transcription factors, such as AP-1, NFB, and p53, which are tightly regulated and balanced by the cellular antioxidant system (5-7). Macrophages, neutrophils, and eosinophils are an additional source of endogenous ROS production and fight pathogens by a transient respiratory burst of oxidative stress, indicating another crucial involvement of ROS in cellular maintenance (8) . Nevertheless, chronic oxidative stress frequently occurs as a consequence of an imbalanced intracellular redox status, promoting a variety of pathologies, such as malignant diseases, type II diabetes, atherosclerosis, chronic inflammation, ischemia/reperfusion injury, and many neurodegenerative diseases (9) . Acute high ROS levels damage cellular compartments, leading to inactivation and malfunction of various enzymes, as excess amounts of O 2 Ϫ⅐ directly oxidize and inactivate iron-sulfur complex-containing proteins. Mitochondrial dysfunction has been shown to play a key role in the induction of apoptosis (10, 11) . Impaired mitochondrial functions lead to the suppression of mitochondrial metabolism, imbalanced mitochondrial membrane potential, reduced respiration, and oxidative phosphorylation (6) , and finally trigger cells into apoptosis (12) .
This basic knowledge on ROS signaling has been utilized for the development of novel therapeutic applications in human diseases. Besides treatment of patients with antioxidants to prevent cardiovascular and neurodegenerative diseases and cancer (13, 14) , recent research revealed that cells with an imbalanced redox homeostasis are more susceptible to oxidative stress-induced apoptosis than normal cells. Therefore, ROS-generating drugs might be very effective in treating malignant diseases by disrupting mitochondrial functions and inducing apoptosis (15) . Several dietary polyphenols have been well investigated with respect to antioxidant action, and mechanistic modes of activity have been described previously (16) . However, more recent publications state that in addition to antioxidant potential, many polyphenols exert prooxidant properties at low concentrations (17) and therefore might selectively trigger cells with an imbalanced redox homeostasis into apoptosis by the induction of excessive ROS formation (18) .
One natural antioxidative polyphenol is xanthohumol (XN), a prenlyated chalcone derived from hops (Humulus lupulus L.). XN exerts a broad spectrum of chemopreventive actions, such as inhibiting the initiation, promotion, and progression of malignant tumors in vitro and in vivo (19, 20) . XN has antiproliferative properties and induces apoptosis in several cancer cell lines, including leukemia cell lines, prostate cancer, and hepatoma cell lines (summarized in ref. 21 ). Down-regulation of Bcl-2 protein expression; activation of caspases-3, -7, -8, and -9; and poly(ADP-ribose)polymerase (PARP) cleavage were found to contribute to apoptosis induction via both the extrinsic as well as the intrinsic apoptotic pathway in cultured human colon cancer cells (22) . Induction of apoptosis and differentiation by XN in preadipocytes were linked to the induction of ROS (23, 24) . Recently, XN has been reported to activate the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemia (25) .
The aim of the present study was to elucidate mechanisms involved in putative prooxidant activities of XN as a trigger of antiproliferative activity. We have monitored the formation of superoxide anion radicals (O 2
Ϫ⅐
) by XN and measured disruption of the intracellular redox balance and inhibition of the complexes of the mitochondrial respiratory chain. Further, we investigated mitochondrial integrity via the loss of mitochondrial membrane potential, release of cytochrome c (cyt c), and induction of apoptosis. Our results suggest that XN shares functional similarities with "mitocans," a newly defined class of therapeutic and preventive drugs that selectively target mitochondria, destabilize them, and therefore efficiently kill cells with an imbalanced redox homeostasis (26) .
MATERIALS AND METHODS

Chemicals
XN (CAS 6754-58-1) was obtained as hop-derived ethanolic extract with 80% purity (Hallertauer Hopfenverwertungsgesellschaft, Mainburg, Germany) and purified by silica gel column chromatography with n-hexane/ethyl acetate solvent essentially as described previously (19) . Purity measured by HPLC was Ͼ99%. RPMI 1640 and DMEM, FBS, and trypsin/ EDTA were purchased from Invitrogen (Karlsruhe, Germany). Manganese (III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP) was from A.G. Scientific, Inc. (San Diego, CA, USA). All materials required for flow cytometry were purchased from Becton Dickinson (Franklin Lakes, NJ, USA). Anti-cyt c antibody was from Clontech (San Diego, CA, USA), and anti-PARP (556362) antibody was from BD Pharmingen (Heidelberg, Germany). PCR Immolase Taq polymerase was obtained from Bioline (Taunton, MA, USA), deoxynucleotide triphosphates were from Eppendorf (Hamburg, Germany), and primers were synthesized by Sigma-Aldrich (Taufkirchen, Germany). Materials and equipment for gel electrophoresis were from Bio-Rad (Munich, Germany). All other chemicals were purchased from Sigma-Aldrich or as stated otherwise. FVB/N mice were purchased from Charles River Wiga (Sulzfeld, Germany) and housed in a controlled environment at 20°C on an illumination schedule of 12 h light and darkness each day.
Cell culture
BPH-1 cells, derived from human benign hyperplasia, were cultured in RPMI 1640 medium supplemented with 10% charcoal-stripped fetal bovine serum (FBS) and 10 g/ml hydrocortisone, 1 g/ml insulin, 50 ng/ml testosterone, and 5 g/ml transferin, as described previously (27) . Cyt c GFPlabeled MCF-7 cells were established by Dussmann et al. (28) and grown in DMEM, supplemented with 10% FBS at 37°C and 5% CO 2 in a humidified atmosphere. Both cell lines were seeded at a density of 5 ϫ 10 4 cells/ml.
Determination of O 2 ؊⅐ in cell culture and isolated mouse liver mitochondria
Cells were seeded in 96-well plates and grown overnight. After removal of cell culture medium, cells were washed with PBS, and 190 l of 25 M dihydroethidium (DHE) dissolved in PBS was added to each well. Immediately before the measurement was started, 10 l of XN, other compounds as indicated, or solvent control (10% DMSO, 0.5% final concentration) was added, and the time-dependent increase in fluorescence (DHE ex/em: 530/620 nm) was measured using a CytoFluor series 4000 multiwell plate reader (PerSeptive Biosystems, Freiburg, Germany) for 20 min at 37°C.
To measure transient O 2 Ϫ⅐ formation by XN, cells were seeded in 96-well plates, grown overnight, and treated with 12.5 M XN for increasing time points as indicated. Then, cells were washed with PBS once, and 200 l of 25 M DHE dissolved in PBS was added to each well. Increase in fluorescence (DHE ex/em: 530/620 nm) was measured using a CytoFluor series 4000 multiwell plate reader (PerSeptive Biosystems) for 20 min at 37°C.
Mitochondria were isolated from livers of male FVB/N mice, 4 -6 mo of age, that were starved overnight, essentially as described earlier (29) . To determine O 2 Ϫ⅐ formation in isolated mitochondria, mitochondria were suspended in 190 l warm PBS containing 25 M DHE to a final protein concentration of 0.3 mg/ml. Immediately before the measurement was started, 10 l of XN, other compounds as indicated, or solvent control (10% DMSO and 0.5% final concentration) was added, and the time-dependent increase in fluorescence (DHE ex/em: 530/620 nm) was measured using a CytoFluor series 4000 multiwell plate reader for 20 min at 37°C.
Determination of H 2 O 2
For the determination of H 2 O 2 , an Amplex Red hydrogen peroxide/peroxidase assay kit (Invitrogen) was utilized according to the manufacturer's instructions. In cell-free incubations, cell culture medium was mixed with Amplex red dye, horseradish peroxidase (HPR), and XN or (Ϫ)-epigallocatechin-3-gallate as positive control, respectively. Alternatively, Amplex Red dye and HPR were added to cultured BPH-1 cells, and the release of H 2 O 2 was measured accordingly. H 2 O 2 levels were quantified in comparison with a H 2 O 2 standard curve.
Inhibition of XN induced O 2
؊⅐ formation
Cells were seeded in 96-well plates, grown overnight, and washed with PBS once. Then, 190 l of warm PBS, containing ascorbic acid or N-acetylcysteine (NAC) as indicated, and 25 M DHE was added to each well. Immediately before fluorescent measurements were started, XN (10 l, freshly dissolved in 10% DMSO/RPMI cell culture medium, supplemented with 10% FBS, 10 M final concentration) or solvent control (10% DMSO, 0.5% final concentration) was added. Time-dependent increase in fluorescence was monitored Ͼ20 min. To measure inhibition of O 2 Ϫ⅐ formation by the SOD mimetic MnTMPyP, BPH-1 cells were preincubated with MnTMPyP dissolved in cell culture medium for 1 h. Then, plates were washed once with PBS and treated as described above. The rate of increase in fluorescence of cells treated with 10 M XN alone was set as 100% and inhibition by antioxidants and MnTMPyP was calculated accordingly.
Determination of total, oxidized, and reduced thiols
To determine total thiol levels, BPH-1 cells were seeded in 96-well plates, grown overnight, and treated with increasing XN concentrations (dissolved in DMSO, final solvent concentration 0.5%) for 6 h. Then, cells were once washed with PBS and total sulfhydryl (SH) content per well was determined using 5,5Ј-dithiobis(nitrobenzoic acid) (Ellman's reagent) as described previously (30) . To measure oxidized and reduced thiols, BPH-1 cells were seeded in 10-cm cell culture dishes (5ϫ10 4 cells/ml, 10 ml/dish) and grown overnight as described above. Then, medium was changed, and XN was added at increasing concentrations, as indicated. DMSO was used as a solvent control (0.1% final concentration). After incubation for various time intervals as described, cells were washed with PBS, collected in 250 l PBS, and snap-frozen in liquid nitrogen. After thawing and removal of cellular fragments by centrifugation (14,000 g max, 10 min, 4°C), the total SH content of cell lysates was determined (30) . To measure total oxidized thiol levels using GSSG as a standard, free SH groups were masked with 1.25% 2-vinylpyridine, dissolved in 125 mM Na 2 HPO 4 supplemented with EDTA 6.3 mM (pH 7.5,) for 1 h, and then processed as described previously (30) . Reduced thiol levels were calculated by the difference of total SH and GSSG levels. All oxidized and reduced thiol concentrations were normalized to the total protein content.
Fluorescence microscopy images of cyt c GFP-MCF-7
Cyt c GFP-MCF-7 cells were seeded in chamber slides (Nunc, Rochester, NY, USA) at 5 ϫ 10 4 cells/ml in DMEM, supplemented with 10% FBS, and grown overnight. Cell culture medium was changed to phenol red-free DMEM plus 10% FBS. To measure mitochondrial O 2 Ϫ⅐ formation, cyt c GFP-MCF-7 cells were first stained with Hoechst 33342 (1 g/ml) for 10 min, and then 25 M XN was added and incubated for 10 min. Medium was disposed, cells were washed once with PBS, and cell culture medium containing 5 M MitoSOX Red was added. After 5 min incubation, confocal images were taken (MitoSOX Red ex/em: Ar 514/580 nm). For time-lapse imaging, cyt c GFP-MCF-7 cells were first stained with Hoechst 33342 (1 g/ml) for 10 min and then XN at a final concentration of 50 M was added, and images were taken with a confocal fluorescence microscope (Leica, Wetzlar, Germany) equipped with a temperature and CO 2 -controlled microscope stage (Cyt c GFP ex/em: Ar 488/500 -550 nm; Hoechst ex/em: diode 405/530 nm). Scans were recorded every 10 min for 1 h in total.
Generation of BPH-1 pseudo-0 ( 0 ) cells BPH-1 0 cells were generated by addition of 250 nM ethidium bromide and 50 g/ml uridine to RPMI 1640 cell culture medium for 8 d and a minimum of 2 passages (31). Then, cells were seeded in regular RPMI 1640 medium, and measurements of ROS production were performed as described above. To confirm depletion of mitochondria, DNA expression of "mitochondrial origin of replication" was quantified by PCR, as described previously (32) .
Mitochondrial respiratory chain complex inhibition studies
Submitochondrial particles (SMPs) from bovine heart were prepared as described previously (33) , and the catalytic activities of respiratory chain complexes I-IV were investigated (34) . In brief, complex I activity was detected by NADH oxidation, complex II activity was detected by dichloroindophenol reduction, and complex III activity was assessed by cyt c reduction. Complex IV activity was measured by cyt c oxidation. Incubation with specific inhibitors of complexes I-III, i.e., with 2-n-decylquinazolin-4-yl-amin (DQA), malonate, and stigmatellin, led to 80 -97% (PϽ0.001) inhibition of complex activities, confirming specific enzymatic activities in our assay system. Impact of XN on electron flux from complex I to complex III and from complex II to complex III was measured in mitochondria from BPH-1 cells. In brief, trypsinized BPH-1 cells were pelleted and lysed by 15ϫ resuspension through a 22-gauge needle. After centrifugation (600 g, 10 min, 4°C), the mitochondria-containing fraction was used to measure complex activity in the presence of 6.25-50 M XN, essentially as described previously (34), using NADH and succinate, respectively, as substrates and following cyt c reduction in the presence of NaCN.
Cellular ATP measurement
BPH-1 cells were seeded in cell culture-treated white 96-well plates (Greiner, Frickenhausen, Germany) and grown over-night. Cell culture medium was changed, and cells were treated with increasing concentrations of XN and for several time intervals as indicated and washed with PBS once, and 200 l cell culture medium containing 50% (v/v) CellTiter Glo (Promega, Madison, WI, USA), was added to each well. After 10 min of incubation at room temperature, chemiluminescence was measured using a Spectra Max M5 E instrument (Molecular Devices, Sunnyvale, CA, USA). Cellular ATP levels were quantified based on an ATP standard curve in the range of 0 -250 pmol/l and normalized to protein levels.
Measurement of mitochondrial membrane potential and cyt c release
Mitochondrial membrane potential (⌬⌿ m ) was measured using the dye JC-1 (5,5Ј,6,6Ј-tetrachloro-1,1Ј,3,3Ј-tetraethylbenzimidazolylcarbocyanine iodide). BPH-1 cells were grown overnight. Cell culture medium was changed, and cells were treated with varying concentrations of XN for several time intervals, as indicated. Cell culture medium was removed and replaced with medium containing JC-1 (1 g/ml, diluted 1:2500 from stock prepared in DMSO) for 30 min at 37°C. After being washed once with PBS, cells were pelleted by centrifugation (600 g max, 5 min, 4°C). The pellet was resuspended in PBS containing 1 mM EDTA and analyzed with a FACS Calibur (photomultiplier set at ϳ390 V in FL1 and ϳ320 V in FL2, FL-1-FL2 compensation ϳ4.0% and FL2-FL1 compensation ϳ10.6%). Loss of ⌬⌿ m was quantified by quadrant analysis, with the bottom right quadrant representing cells with disrupted membrane potential (loss of red fluorescence).
Cyt c release was detected by Western blotting in cytosolic fractions of BPH-1 cells treated with XN for various time intervals as indicated or in a dose-dependent manner after 24 h of treatment. To generate cytosolic extracts, treated BPH-1 cells were trypsinized, pelleted, resuspended in PBS, and snap frozen in liquid nitrogen. After removal of cellular fragments by centrifugation (14,000 g max, 10 min, 4°C), 2.5 g of total cytosolic protein was subjected to SDS-PAGE (15% acrylamide) under standard conditions (35) . Cytosolic cyt c was detected using anti-cytochrome c antibody (Clontech, San Diego, CA, USA; diluted 1:1000 in 5% milk/TBS-T and incubated at 4°C overnight).
Cytotoxicity assay
Sulforhodamin B staining was performed as described earlier (36) . To measure the influence of MnTMPyP and NAC treatment on XN-induced cytotoxicity, cells were preincubated with 50 M MnTMPyP for 1 h before addition of XN or cotreated with 2 mM NAC.
Cell cycle distribution and Western blot analyses
Cell cycle distribution and detection of PARP cleavage by Western blotting was carried out as described previously (37) . To measure protective effects of MnTMPyP on XN-induced cell cycle arrest and induction of apoptosis, cells were preincubated with 50 M MnTMPYP for 1 h before addition of XN.
Statistical analysis
Results are presented as means Ϯ sd. For statistical evaluation, 1 and 2-way ANOVA analysis and Tukey's HSD multiple comparison test or Student's t test was applied using JMP Statistical Discovery software (SAS Institute, Cary, NC, USA). Values of P Ͻ 0.05 were considered significant.
RESULTS
XN treatment induces formation of superoxide anion radicals
To detect prooxidative potential of XN, we utilized 2 redox-sensitive fluorescent indicators. Initial experiments with 2Ј,7Ј-dichlorodihydrofluorescein diacetate (H 2 DCF-DA) revealed an immediate and dose-dependent increase in fluorescence after addition of XN to BPH-1 benign prostatic hyperplasia cells (Supplemental Fig. S1 ). Since H 2 DCF-DA is oxidized unspecifically under conditions of "generalized oxidative stress" (38), we used DHE, which is more specifically oxidized by O 2 Ϫ⅐ , for all subsequent experiments. Cotreatment of BPH-1 cells with 12.5 M XN and 25 M DHE caused an immediate increase in DHE oxidation to fluorescent 2-hydroxyethidium (39), indicative of O 2 Ϫ⅐ induction by XN. In the absence of cells, there was no increase in DHE oxidation by XN (not shown). Antimycin A, a complex III inhibitor of the mitochondrial respiratory chain, served as positive control for the induction of O 2 Ϫ⅐ , and we observed similar kinetics of DHE oxidation with both compounds at a test concentration of 12.5 M (Fig. 1A) Fig. 2A, B) . Pretreatment of BPH-1 cells with the cell permeable superoxide dismutase (SOD)-mimetic MnTMPyP [manganese (III) tetrakis(1-methyl-4-pyridyl)porphyrin] in a concentration range of 1.6 -50 M for 1 h before induction of O 2 Ϫ⅐ by addition of 10 M XN also significantly reduced DHE oxidation (PϽ0.001 at 50 M MnTMPyP), and we determined an IC 50 value of 7.0 Ϯ 2.2 M (Fig. 2C ).
XN-induced O 2
؊⅐ formation leads to thiol oxidation and depletion Glutathione (GSH) constitutes the major intracellular antioxidant defense against ROS and has been shown to scavenge O 2 Ϫ⅐ and other ROS by oxidation to thiyl radical and further oxidation to GSSG (41) . Therefore, we determined changes in intracellular thiol-disulfide levels as a consequence of XN treatment using GSH and GSSG as standards. BPH-1 cells were treated with increasing XN concentrations, and after 6 h total thiol levels were determined. Increasing XN concentrations caused a significant (PϽ0.001 at 25 and 50 M) dosedependent depletion of total thiols of 17-62%, and we calculated an IC 50 value of 24.3 Ϯ 11 M (Fig. 3A) . To test whether XN-induced O 2 Ϫ⅐ formation would cause oxidation of GSH to GSSG, BPH-1 cells were treated with 50 M XN, and after incubation for 0.5-6 h, oxidized and reduced thiol levels were measured. As early as 30 min after addition of XN, GSSG levels were significantly elevated by 15% compared with solvent controls cells (PϽ0.001), and this increase remained constant up to 6 h after XN treatment (Fig. 3B) . In parallel, reduced thiol levels were significantly depleted by XN treatment in a time-dependent manner with 68% reduction after 6 h (PϽ0.05; Fig. 3C ). Alternatively, increased GSSG levels may be due to XN oxidation by intracellular oxidases and peroxidases in the presence of GSH or NADH and catalytic amounts of H 2 O 2 , as suggested by Galati et al. (42) (Supplemental  Fig. S3 ).
XN-induced O 2 ؊⅐ formation is of mitochondrial origin
Fluorescence microscopy after staining of BPH-1 cells with the mitochondrial superoxide indicator MitoSOX Red gave a first indication that mitochondria might be the source of XN-induced O 2 Ϫ⅐ (not shown). Consequently, we isolated mitochondria from murine liver to measure O 2 Ϫ⅐ -induction by XN. Mitochondria (0.3 mg/ ml) were suspended in PBS containing 25 M DHE and then treated with XN and antimycin A, respectively, in a concentration range of 1.6 -25 M. Similar to the results obtained with intact cells, both compounds caused an immediate, dose-dependent increase in DHE oxidation (EC 50 ϭ11.4Ϯ1.8 and 12.4Ϯ0.9 M, respectively), indicating that mitochondria were indeed targeted by XN (Fig. 4A) .
This observation was further investigated using MCF-7 cells stably transfected with GFP-labeled cytochrome c (cyt c GFP; ref. Ϫ⅐ generation, which was much less pronounced in solvent-treated control cells (Fig. 4B) (Fig. 4C) . Reduction in functional mitochondria in BPH-1 0 cells was confirmed by PCR amplification of origin of replication of mitochondrial heavy strand DNA (Fig. 4D) . Further, BPH-1 0 showed reduced respiratory activity, compared with normal BPH-1 cells, confirming a lack of intact mitochondria (not shown).
XN inhibits complexes I-III of the respiratory chain and depletes ATP
Inhibition of mitochondrial respiration leads to an increased release of O 2 Ϫ⅐ , as indicated by the results obtained with the complex III inhibitor antimycin A (Figs. 1A and 4A) . Therefore, we were wondering whether mitochondrial respiration was a target of XN action. We monitored oxygen consumption of isolated mouse liver mitochondria using a Clark-type oxygen electrode (Hansatech, Norfolk, England). After addition of 100 M ADP, oxygen consumption was increased, indicating active, electron absorbing complex V activity (ATPase). This respiratory state was significantly inhibited by the addition of both XN and antimycin A at a concentration of 100 M (PϽ0.05; Supplemental Figure S4) .
We next performed detailed complex inhibition studies with SMPs isolated from bovine heart. As depicted in Table 1 , XN had to be tested at relatively high concentrations from 50 to 200 M to achieve inhibition of the individual complexes I, II, and III, owing to the high abundance of respiratory chain proteins in SMPs. NADH:ubiquinone oxidoreductase (complex I) activity, succinate dehydrogenase (complex II) activity, as well as complex III activity (cytochrome bc 1 complex) were significantly inhibited by XN at concentrations Ͼ100 M (PϽ0.05), whereas cytochrome c oxidase (complex IV) activity detected by cyt c oxidation was not affected by XN (data not shown). Overall, XNmediated inhibition of individual complexes of the respiratory chain appeared to be unspecific, and we cannot exclude that it may be due to protein binding or complexation with iron. Accordingly, we could demonstrate in vitro chelation of XN with Fe Fig. 7B (PϽ0.05, 2-way ANOVA) . This effect was significantly inhibited by 35-61% by pretreatment with 50 M MnTMPyP for 1 h (PϽ0.001, 2-way ANOVA).
Usually the opening of the outer mitochondrial membrane is accompanied by the release of cyt c into the cytosol. Therefore, we assessed the effects of XN on cyt c release from mitochondria using confocal microscopy live cell imaging with GFP cyt c labeled MCF-7. Cells were treated with 50 M of XN, and images were taken immediately after the addition of XN and every 10 min for 60 min. As early as 10 min after XN treatment, we observed changes in mitochondrial cyt c organization (Fig. 7C, center panel) , which were more pronounced after 30 min of treatment and did not appear in DMSO-treated control cells (Fig. 7C, top  panel) . After 1 h of XN treatment, fluorescing cyt c GFP molecules were no longer detectable in mitochondria. Again, pretreatment with 50 M MnTMPyP for 1 h almost completely abrogated XN-mediated effects on cyt c release (Fig. 7C, bottom panel) .
In parallel, Western blots of cytosolic protein fractions of BPH-1 cells treated with 25 M XN demonstrated a time-dependent release of cyt c into the cytosol. Elevated cytosolic cyt c levels were detectable already 30 min after addition of XN and further increased until 24 h of incubation (Fig. 7D) . After 24 h, a dose-dependent cyt c release was confirmed with (Fig. 7E) .
Antiproliferative effects and apoptosis induction are reduced by MnTMPyP
XN has been shown to possess antiproliferative activity and to induce apoptosis via down-regulation of Bcl-2 protein expression; activation of caspases-3, -7, -8, and 9; and PARP cleavage (22) . To test whether these mechanisms are initiated by the immediate induction of 
DISCUSSION
Based on a previous observation that induction of apoptosis and differentiation of preadipocytes by XN have been linked to the induction of ROS (23, 24) , the aim of the present study was to elucidate the kinetics, source, and downstream events of XN-induced ROS formation.
ROS are important regulators of apoptosis (2), either by directly activating apoptosis via mitochondria or as a consequence of mitochondria-mediated induction of apoptosis (45) . In the present study, we demonstrated that XN very rapidly induces O 2 Ϫ⅐ and that mitochondria are the source of this increase. Complex inhibition studies in submitochondrial particles and in mitochondria from BPH-1 cells revealed the inhibitory potential of XN at complexes I to III of the respiratory chain. Subsequent damage of mitochondrial integrity led to the loss of mitochondrial membrane potential, depletion of ATP, release of cyt c, and induction of apoptosis, detectable by PARP cleavage and an increase in the sub-G 1 fraction by flow cytometry. Importantly, we prevented almost all of these steps by pre-or cotreatment with an SOD mimetic or antioxidants, indicating that O 2 Ϫ⅐ induction is indeed the trigger for cell death. After having established this relationship, we were interested in the molecular mechanisms that may contribute to the immediate mitochondrial O 2 Ϫ⅐ production induced by XN. The major function of mitochondria is to carry out oxidative phosphorylation to produce ATP. Inhibition of complexes I and III has been shown to result in rapid, excessive O 2 Ϫ⅐ formation (46) . We demonstrated inhibitory effects of XN at complexes I to III and on electron flux between complex I or II and III, which might derive from direct interaction of XN with the respective enzymes. Ironbinding properties are typical features of polyphenols (47, 48) . Interestingly, incubation of XN with Fe 2ϩ and Fe 3ϩ ions, as well as with the Fe 2ϩ -porphyrin complex hemin, resulted in dose-dependent interactions with XN ( Supplemental Fig. S5 ). Based on these data, we speculate that XN may bind to iron atoms and thereby inhibit iron-sulfur-complexes of respiratory chain proteins. Moreover, specific binding of XN to intracellular proteins has been demonstrated earlier (49) . Recent work (50) also suggested XN-thiol adduct formation in a Michael-type addition reaction as a consequence of XN oxidation in vitro. These findings provide another potential mechanism of how XN interacts with enzymes of the respiratory chain and thus alters mitochondrial respiration.
Excessive O 2 Ϫ⅐ formation has been related to a breakdown of the mitochondrial membrane potential and uncoupling of respiration (46, 51) . Many phenolic compounds, such as the dietary curcumin and its derivatives, but also classical uncouplers such as CCCP or 2,4-dinitrophenol induce mitochondrial uncoupling and mitochondrial permeability transition pore (MPTP) opening, resulting in the collapse of the mitochondrial membrane potential (52, 53) . XN-induced O 2 Ϫ⅐ formation was accompanied by an immediate breakdown of the mitochondrial membrane potential. In contrast to other phenolic compounds, XN lacks uncoupling activity, despite the fact that XN contains several acidic dissociable groups that could induce uncoupling (54) . XN did not induce mitochondrial swelling (data not shown), which is an indicator of MPTP opening (53) . Nevertheless, XN treatment caused thiol group oxidation in isolated mitochondria (Supplemental Fig. S6 ), which is, beside increased ROS production and a low mitochondrial membrane potential, believed to be one of the triggers for MPTP opening (11) . As a consequence of MPTP opening, the release of proapoptotic factors and subsequent apoptosis are induced (55) .
Apoptosis is an energy-dependent process, and a rapid loss of ATP is normally linked to necrotic cell death (56) . XN treatment significantly depleted intracellular ATP levels in a dose-dependent manner. XN at a concentration of 12.5 M, which induced the highest O 2 Ϫ⅐ formation, caused a 25% depletion of ATP, most likely as a direct consequence of disrupted mitochondrial respiration. In contrast, higher XN concentrations led to a very rapid drop in ATP concentration of up to 95% after 15 min already. However, no signs of necrosis were measured by PI exclusion at concentrations up to 50 M used in the present study after 72 h of XN treatment (data not shown). In contrast, XN treatment rapidly induced the release of cyt c from mitochondria into the cytosol, which is one of the initial and irreversible steps of apoptosis induction. Previous studies showed down-regulation of antiapoptotic Bcl-2 expression and activation of caspases-3, -7, -8, and -9 by XN (22) . Strikingly, in the present study, downstream events of apoptotic cell death, such as PARP cleavage and accumulation of cells in the sub-G 1 phase of the cell cycle were detected after 48 h of treatment only, whereas cyt c release was observed as early as 30 min after XN treatment. Unpublished data from our laboratory have recently indicated that XN induces autophagy, representing a mechanism of cell survival at times of stress (56, 57) . Autophagy often occurs when cells are not able to maintain ATP levels or when mitochondria are damaged (58) . Inhibitors of the respiratory chain have been identified before as inducers of autophagy, with O 2 Ϫ⅐ being the major regulator (59, 60) . Prolonged autophagy can result in the induction of cell death (59) , and this may explain why induction of apoptosis by XN-induced O 2 Ϫ⅐ formation as an initial trigger is delayed. Interestingly, antioxidant treatment prevented XN-induced autophagy (unpublished results). However, the detailed mechanism of XN-induced autophagy and its relation to apoptosis need to be further investigated.
As a sign of intracellular oxidative stress, we detected elevated GSSG levels and total thiol depletion on XN treatment. An unbalanced redox environment is an important regulator of progression to apoptosis (61) . Accordingly, the action of various cytotoxic agents has been linked to induction of oxidative stress, depletion of intracellular GSH, and consequent apoptosis induction (62, 63) . Induction of mitochondria-derived ROS was identified as an apoptotic stimulus acting via GSH oxidation and depletion, oxidative protein modifications, activation of caspases, and downregulation of antiapoptotic signaling molecules (41) .
By now it is well accepted that many pathologies are associated with increased levels of ROS, which promote abnormal proliferation and imbalanced redox homeostasis (64, 65) . It is believed that cancer cells display an aberrant redox balance and altered stress adaption compared with normal cells. Elevated levels of ROS concomitant with elevated expression of the intracellular antioxidant system have been described in cancer cells in vitro as well as in vivo. These changes might be initiated either by the expression of oncogenes, such as c-myc and Ras, which were found to cause ROS induction, and/or by down-regulation of tumor suppressor genes (e.g., TP53), altered metabolism, and mitochondrial functions (15) . Persistent oxidative stress makes affected cells more sensitive to prooxidant exposure, leading to destabilization of mitochondria and the induction of apoptosis (26, 66) . On the contrary, normal cells with basal ROS levels are affected by oxidative stress to a lower extent (67) . Consequently, mitochondria have emerged recently as effective targets for cancer therapeutic drugs, referred to as "mitocans" (for mitochondria and cancer; ref. 66) . Distinct targets of mitocans have been identified, including but not limited to voltage-dependent anion channels, the complexes of the respiratory chain, antiapoptotic proteins Bcl-2 and Bcl-x L , and other mitochondrial membrane bound enzymes (26) . One key mechanism of mitocans involves the generation of ROS of mitochondrial origin, which are believed to mediate mitochondrial oxidation processes, which then trigger the induction of apoptosis (26 An initial safety study (69) in rats revealed no severe toxic side effects of XN when it was applied orally at doses of 10 and 100 mg/kg body wt/d for extended periods of time. Peak plasma concentrations after a single application of 1000 mg XN/kg body wt to female Sprague-Dawley rats were detected 4 h after oral application. The XN-4Ј-O-glucuronide was identified as the major metabolite, with a maximal concentration of 3.1 M. Unmetabolized XN was detectable with a maximal concentration of 0.34 M 4 h after administration (20) . Different routes of applications and improved formulations (currently under development) should improve bioavailability for preventive and therapeutic use.
In summary, the present study presents a novel mechanism of XN-mediated action. By inducing the O 2 Ϫ⅐ of mitochondrial origin, followed by disruption of mitochondrial integrity and induction of apoptosis, XN may represent a new member of mitocans. The current findings and future studies will reveal if prooxidant effects are relevant in rodent models of carcinogenesis and will open interesting perspectives in the research on therapeutic strategies by using dietary polyphenols such as Xanthohumol. These titrations indicate that XN most likely forms complexes with Fe 2+ and Fe 3+ in a ratio of 1:1 and 1:2, respectively. Titration of XN with haemin suggests a shift in π-electrons of XN, resulting in an immediate loss of absorption of XN.
